May 17, 2020

Neovii Pharmaceuticals names its new CEO

Catherine Sturman
2 min
Juergen Pohle
Set to take over the role in January, Juergen Pohle will become Neovii Pharmaceuticals new Chief Executive Officer. He is currently the company’s Chie...

Set to take over the role in January, Juergen Pohle will become Neovii Pharmaceuticals new Chief Executive Officer. He is currently the company’s Chief Commercial Officer.

With a patient-focused mission to develop and market novel life-transforming therapies, Neovii has become a biopharmaceutical company with a global presence, and a leader in improving the outcomes in transplantation medicine and treatment options for haemato-oncological as well as immune disorders.

"Neovii has significantly expanded with increasing performance, paving the way to become a recognized player in transplantation medicine," commented current CEO Alexandre Sudarskis. He will continue to support Neovii as Executive Director and member of Neovii Pharmaceuticals Board.

Becoming Head of Marketing and Sales Consulting for Bayer Healthcare in Germany back in 2002, Pohle rose to become Head of Business Strategy & Intelligence, before moving to Novartis Pharma as Head of Business Development and Licensing, gaining further roles in Switzerland and the Czech Republic at the company.

Related stories

Speaking four languages: English, Germany, French and Italian, Pohle joined Neovii Pharmaceuticals in Switzerland in 2016, and has gained over 15 years’ experience in the pharmaceutical industry.

Most recently, he has led the business for Emerging Growth Markets and Institutional Customers such as UNICEF for Novartis Vaccines and Diagnostics AG in Basel.

Chairman David Fuhrer commented: "Juergen's leadership skills, his long-term proven track record and his many years of international experience in the pharmaceutical industry make him the ideal candidate for the position of CEO.

We are extremely pleased that Juergen has embraced the challenge of further driving the development and growth of Neovii."

Share article

Jun 14, 2021

Zoom enters the healthcare market - a timeline

3 min
We chart Zoom's rise and entrance into the healthcare market

Since the pandemic began Zoom has become an integral part of daily life for people working from home, as well as a vital tool for families and friends to communicate. However it's also been eyeing up the healthcare space since 2017, and following the boom in telehealth the company has been rolling out additional services. Here we chart Zoom's move into healthcare. 

2011 - 2013

Zoom is founded in San Jose, California, by Eric Yuan, formerly of Cisco. He got the idea to create a video calling platform from his visits to his girlfriend while he was a student, which would take 10 hours by train. 

A beta version is released in 2012, which can host up to 15 participants. In 2013 this rises to 25. By mid-2013, Zoom has 1 million users. 

2014 - 2017

Zoom attracts investors, including Sequoia Capital, Emergence and Horizon Ventures. By January 2017, Zoom has a series D funding worth $100 million.

2017 - 2019

Zoom for Telehealth launches, including an integration with EHR system Epic. It has cloud-based video, audio, and content sharing features, a "waiting room" for patients, and can easily be integrated into healthcare provider's workflows. 

In 2019 Zoom goes public, with its IPO rising 72% in one day. 


As a result of the pandemic, Zoom gains 2.2 million new users, more than in the whole of 2019. On the 23rd of March alone - the day the UK lockdown was announced - the platform was downloaded 2.13 million times around the world. 

Share prices rise to around $150, and founder and chief executive Eric Yuan becomes one of the world's richest people, with an estimated net worth of $7.9 billion. 

Early security issues are addressed by encrypting data with the Advanced Encryption Standard (AES). By now the the platform allows 99 people to be on a call simultaneously
New features launch, including Zoom Home and Zoom for Chats. Throughout the year the platform is used to replace most kinds of real life events: work meetings, online classrooms, church services and social events. 


Renamed Zoom for Healthcare, users can share secured video, audio, and content through desktops, mobile phones, and conference devices. As well as Epic, it can be integrated with Strmr, IntakeQ, and Practice Better.

It can also be used with diagnostic cameras and other point-of-care devices, including digital stethoscopes.

In an interview with Korea Biomedical Review, Zoom Global Healthcare Lead Ron Emerson said: "Our service is not simply a virtual care and telemedicine platform but a multi-purpose platform that can satisfy the needs of healthcare institutions."

"It can be used for administrative tasks, including telemedicine, medical team meetings, recruitment, medical education, employee training, and disease prevention. Analysing electronic records managed by Zoom could provide meaningful insights into patient care." 

Phoenix Children's Hospital, Belfast's Hospital Services Limited, Butler Health Services and the global Project ECHO are among Zoom for Healthcare's current customers. 

Share article